跳至主要内容
临床试验/NCT02278107
NCT02278107Unknown不适用

Evaluation of a Lightweight Nasal Interface and Ventilator for Use by Patients With Respiratory Disease

New Aera, Inc0 个研究点目标入组 20 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
主要终点
Exercise Endurance Time to Maximum Tolerance

研究概览

简要总结

A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.

详细描述

An open-label, randomized, controlled, crossover study in patients with severe chronic lung disease to evaluate exercise tolerance compared to standard nasal cannula oxygen therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult male or female (> 18 years of age) with a diagnosis of severe-to-very severe chronic lung disease
  • Participates in a qualified pulmonary rehabilitation program
  • Requires constant flow oxygen of ≥ 2 LPM (liters per minute) during exercise
  • Able and willing to sign the informed consent
  • Ability to be fitted with the test nasal mask and to use the test ventilator system

排除标准

  • Requires > 5LPM of constant flow to maintain SpO2> 90% during exercise
  • Reports having serious epistaxis within the last 14 days prior to enrollment
  • Currently enrolled in another clinical study or has participated within 30 days of enrollment
  • Has any condition or abnormality that in the opinion of the Investigators may compromise the participant's safety or the quality of the study data

结局指标

主要结局

Exercise Endurance Time to Maximum Tolerance

时间窗: Maximum exercise endurance in minutes, for both treatment arms. Two 4-hr study visits, 1 week apart. Endurance endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.

Endurance measured on cycle ergometer at predetermined constant work rate. Subjects will exercise to their limit of tolerability (max effort).

次要结局

  • Borg 10 Dyspnea Score, Subject reported(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
  • Arterial Oxygen Saturation via Pulse Oximeter (SpO2)(Recorded 1-2 min before and every 1 minute during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
  • Heart Rate(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
  • Leg Fatigue, Subject Reported(Recorded 1-2 min before and every 1 min during exercise testing. Two 4-hr study visits, scheduled 1 week apart. Endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)
  • Adverse Events(Two 4-hr study visits, sheduled 1 week apart. Subjects will be monitored for AEs continuously throughuout the study visit. AEs will be monitored and recored during both study visits.)
  • Respiratory Rate(Recorded 1-2 min before and every 1 min during exercise. Evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.)

研究者

发起方
New Aera, Inc
申办方类型
Industry
责任方
Sponsor

相似试验

Evaluation of a Lightweight Nasal Interface and... | 临床试验